Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as planned, even as star heart drug Camzyos faces new competition. A year ago, in the first quarter of 2025, BMS’ ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A SpaceX Falcon Heavy rocket carrying the National Oceanic and Atmospheric Administration's ...

Falcon Cam at a Manhattan office building revealed the first peregrine falcon to hatch there in years. By James Barron Good morning. It’s Thursday. Today we’ll find out about a newborn in a closely ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Jared Lindzon is the co-author of "Do More in Four: Why It’s Time for a Shorter Workweek" Courtesy Intamin Amusement Rides and Six Flags Qiddiya City The world’s tallest, fastest, and longest roller ...

Bristol Myers Squibb has said it hopes to be ready soon to file for approval of its multiple myeloma drug iberdomide after reporting positive results in a phase 3 trial. Full data from the ...

Learn how to design and craft your own custom laser-cut sign using the Creality Falcon A1. This step-by-step laser tutorial will guide you through the entire process, from setup to the perfect ...

Falcons are a class of birds best known for their speed, vision and hunting prowess. Here’s the story of perhaps the most impressive falcon of all. There are over 35 recognized species of falcons, all ...

Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)–directed antibody‒drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...